Join our live customer webinar on June 18th, 2025 at 15:00 - 16:00 (CEST) / 09:00 - 10:00 (EDT)
Up to 20% of peripheral bypasses fail without a clear cause within the first year, and there's still no standard for completion control. While some hospitals use TTFM and HFUS routinely, there are more clinical questions to be addressed.
Join us in hearing from the lead investigator of the newly started international PATENT study, which was designed to establish evidence-based protocols and reduce graft failure in CLTI patients. You'll also gain real-world insights from a seasoned vascular surgeon using Medistim technology to improve outcomes in daily practice.
Hear from:
Don’t miss this opportunity to gain actionable knowledge and connect with peers in the vascular surgery community.
Økernveien 94, Oslo Norway
Org. nr: 936 656 013
(C) 2024 Medistim ASA